Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Caffeine stimulates central nervous system on a short term. However, the long-term impact of caffeine on cognition remains unclear. We aimed to study the association between coffee and/or tea consumption at midlife and dementia/Alzheimer's disease (AD) risk in late-life. Participants of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study were randomly selected from the survivors of a population-based cohorts previously surveyed within the North Karelia Project and the FINMONICA study in 1972, 1977, 1982 or 1987 (midlife visit). After an average follow-up of 21 years, 1409 individuals (71%) aged 65 to 79 completed the re-examination in 1998. A total of 61 cases were identified as demented (48 with AD). Coffee drinkers at midlife had lower risk of dementia and AD later in life compared with those drinking no or only little coffee adjusted for demographic, lifestyle and vascular factors, apolipoprotein E epsilon4 allele and depressive symptoms. The lowest risk (65% decreased) was found in people who drank 3-5 cups per day. Tea drinking was relatively uncommon and was not associated with dementia/AD. Coffee drinking at midlife is associated with a decreased risk of dementia/AD later in life. This finding might open possibilities for prevention of dementia/AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“though this was found only for coffee intake in two studies [165,169]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [165]
In the citing paper
“while 5 recent studies detected this association only among women or for specific exposures [165,169,171-173]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [165]
In the citing paper
“Finally, large cohort studies of men and women have also found an inverse relationship between caffeine consumption and the risk of Parkinson’s disease (90–92) and Alzheimer’s disease (93–95).”
From The Safety of Ingested Caffeine: A Comprehensive Review (2017) · cites this paper as [94]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 1×
“Caffeine is a nonselective A1 and A2a adenosine receptor antagonist, and thereby it stimulates cholinergic neurons [31].”
WHO MONICA Project Principal Invest (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90084-4 · Cited by 1,794
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261 · cited 3×
“The results are in accordance with previous report from the CSHA study [2] in the elderly, and now extend the effects to”
Kivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70537-3 · Cited by 1,126
Self-citationAssociation of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Effects of caffeine on human behavior
Smith, A. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00096-0 · Cited by 741 · cited 1×
“While short-term central nervous system stimulating effects of caffeine are well known [1], the longterm impact remains unclear.”
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
Kivipelto, M., Helkala, E.-L., Hänninen, T., Laakso, M. P., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · Neurology · doi:10.1212/wnl.56.12.1683 · Cited by 717 · cited 1×
“A more detailed description of the sampling has been described earlier [17] [18] .”
Self-citationProspective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Fruit and Vegetable Juices and Alzheimer’s Disease: The Kame Project
Dai, Q., Borenstein, A. R., Wu, Y., Jackson, J. C., & Larson, E. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.045 · Cited by 529
A case‐control study of Alzheimer's disease in Australia
Broe, G. A., Henderson, A. S., Creasey, H., McCusker, E., Korten, A. E., Jorm, A. F., Longley, W., & Anthony, J. C. (1990) · Neurology · doi:10.1212/wnl.40.11.1698 · Cited by 445
Watson, G. S., & Craft, S. (2003) · CNS Drugs · doi:10.2165/00023210-200317010-00003 · Cited by 397
Neuropathology of Alzheimer’s disease: what is new since A. Alzheimer?
Braak, E., Griffing, K., Arai, K., Bohl, J., Bratzke, H., & Braak, H. (1999) · European Archives of Psychiatry and Clinical Neurosciences · doi:10.1007/pl00014168 · Cited by 372
Dall'Igna, O. P., Fett, P., Gomes, M. W., Souza, D. O., Cunha, R. A., & Lara, D. R. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.008 · Cited by 372
Does caffeine intake protect from Alzheimer's disease?
Maia, L., & De Mendonça, A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00421.x · Cited by 357
Sakhi, A. K., Andersen, L. F., Jacobs, D. R., Blomhoff, R., Svilaas, A., Svilaas, T., Ström, E. C., & Ose, L. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.3.562 · Cited by 349
The neuroprotective effects of caffeine: A prospective population study (the Three City Study)
Ritchie, K., Carrière, I., de Mendonça, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., & Ancelin, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000266670.35219.0c · Cited by 347
Coffee Consumption and Risk of Type 2 Diabetes Mellitus Among Middle-aged Finnish Men and Women
Tuomilehto, J. (2004) · JAMA · doi:10.1001/jama.291.10.1213 · Cited by 281
Self-citationCoffee and tea consumption and the risk of Parkinson's disease
Hu, G., Bidel, S., Jousilahti, P., Antikainen, R., & Tuomilehto, J. (2007) · Movement Disorders · doi:10.1002/mds.21706 · Cited by 280
Self-citationTwenty-Year Trends in Coronary Risk Factors in North Karelia and in Other Areas of Finland
VARTIAINEN, E., PUSKA, P., JOUSILAHTI, P., KORHONEN, H. J., TUOMILEHTO, J., & NISSINEN, A. (1994) · International Journal of Epidemiology · doi:10.1093/ije/23.3.495 · Cited by 271
Self-citationDoes caffeine intake enhance absolute levels of cognitive performance?
Jarvis, M. J. (1993) · Psychopharmacology · doi:10.1007/bf02246949 · Cited by 249 · cited 2×
“It has also been shown that coffee consumption improves cognitive performance [9,10], and this may be primarily due to caffeine.”
Adenosine: does it have a neuroprotective role after all?
de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00033-3 · Cited by 248 · cited 1×
“receptor antagonist [33].”
A case‐control study of Alzheimer's disease
Graves, A. B., White, E., Koepsell, T. D., Reifler, B. V., Van Belle, G., Larson, E. B., & Raskind, M. (1990) · Annals of Neurology · doi:10.1002/ana.410280607 · Cited by 237
Laurin, D. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh124 · Cited by 231 · cited 2×
“In this study and in the previous longitudinal studies [2,5,6], no association was found between tea drinking and the risk of dementia/AD.”
van Gelder, B. M., Buijsse, B., Tijhuis, M., Kalmijn, S., Giampaoli, S., Nissinen, A., & Kromhout, D. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602495 · Cited by 228 · cited 1×
“with the least 10-year cognitive decline [3].”
Future directions in the development of food-frequency questionnaires
Willett, W. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.1.171s · Cited by 194
Coffee Consumption and Cognitive Function among Older Adults
Johnson-Kozlow, M. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf119 · Cited by 173 · cited 1×
“It has also been shown that coffee consumption improves cognitive performance [9,10], and this may be primarily due to caffeine.”
Determination by PCR-RFLP of apo E genotype in a Japanese population.
Tsukamoto, K., Watanabe, T., Matsushima, T., Kinoshita, M., Kato, H., Hashimoto, Y., Kurokawa, K., & TERAMOTO, T. (1993) · PubMed · Cited by 170
Forster, D. P., Newens, A. J., Kay, D. W., & Edwardson, J. A. (1995) · Journal of Epidemiology and Community Health · doi:10.1136/jech.49.3.253 · Cited by 139
A preliminary study of dietary aluminium intake and risk of Alzheimer's disease
Rogers, M. (1999) · Age and Ageing · doi:10.1093/ageing/28.2.205 · Cited by 133
Magnesium in diabetes mellitus
de Valk, H. W. (1999) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(99)00005-4 · Cited by 130
Coffee consumption and the incidence of antihypertensive drug treatment in Finnish men and women
Hu, G., Jousilahti, P., Nissinen, A. M., Bidel, S., Antikaínen, R., & Tuomilehto, J. O. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.457 · Cited by 61
Self-citationCardiovascular Effects of Coffee: Is It a Risk Factor?
Sudano, I., Binggeli, C., Spieker, L., Lüscher, T. F., Ruschitzka, F., Noll, G., & Corti, R. (2005) · Progress in Cardiovascular Nursing · doi:10.1111/j.0889-7204.2005.02477.x · Cited by 51
Coffee consumption is correlated with serum cholesterol in middle-aged Finnish men and women.
Tuomilehto, J., Tanskanen, A., Pietinen, P., Aro, A., Salonen, J. T., Happonen, P., Nissinen, A., & Puska, P. (1987) · Journal of Epidemiology and Community Health · doi:10.1136/jech.41.3.237 · Cited by 45
Self-citationDu, Y., Melchert, H.-U., Knopf, H. C., Braemer-Hauth, M., Gerding, B., & Pabel, E. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-004-7536-x · Cited by 33
Aro, A., Pietinen, P., Uusitalo, U. M., & Tuomilehto, J. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb01367.x · Cited by 28
Self-citation
Cited by
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Beydoun, M. A., Beydoun, H. A., Gamaldo, A. A., Teel, A., Zonderman, A. B., & Wang, Y. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-643 · Cited by 671
Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Cappelletti, S., Daria, P., Sani, G., & Aromatario, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666141210215655 · Cited by 631
Ribeiro, J. A., & Sebastião, A. M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1379 · Cited by 577
The Safety of Ingested Caffeine: A Comprehensive Review
Temple, J. L., Bernard, C., Lipshultz, S. E., Czachor, J. D., Westphal, J. A., & Mestre, M. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00080 · Cited by 557
Metadata
- Authors
- Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M.
- Affiliations
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-01-04
- Volume
- 16
- Issue
- 1
- Pages
- 85-91
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2149637082
- Cited by
- 428
- References
- 38
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 31 · 2023: 30 · 2022: 27 · 2021: 36 · 2020: 25 · 2019: 18 · 2018: 30 · 2017: 21 · 2016: 32 · 2015: 25 · 2014: 35 · 2013: 25 · 2012: 18
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Forskningsrådet för Arbetsliv och Socialvetenskap
- Academy of Finland
- Kuopion Yliopistollinen Sairaala
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- coffee consumption, tea consumption
- MeSH terms
- Aged, Apolipoproteins E, Coffee, Cognition, Data Interpretation, Statistical, Dementia, Diet, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Population, Risk, Risk Factors, Smoking, Tea
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.